Recent Finacing
Recent Raise
Harbour Antibodies engineers transgenic mice (H2L2 and HCAb) that produce human or heavy‑chain‑only antibodies, licenses strains to biotech, pharma and academia, and enables VH‑domain and multispecific antibody generation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor